Pancreatic, hepatic and biliary malignancies

Uncommon genetic aberrations NTRK, RET, NRG

Updates on triple negative breast cancer and immunotherapy

ASCO 2024: Lung cancer highlights

Encouraging results using mismatched unrelated donors in stem cell transplantation

Best practice in HRRm testing in patients with metastatic prostate cancer

Trial argues strongly for the development of 1st-line biomarker selected strategies in pancreatic ductal adenocarcinoma

ARV-766 well tolerated and shows promising clinical activity in metastatic castration-resistant prostate cancer

ASCO 2024: Highlights and analysis

Clinical behaviour of breast cancer in young BRCA carriers and prognostic impact of the timing of genetic testing

Daratumumab plus bortezomib/lenalidomide/dexamethasone in transplant-eligible patients with NDMM: MRD analysis

Looking at real world evidence on PSA testing in prostate cancer